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OBJECTIVE — Dataonlatentautoimmunediabetesinadults(LADA)frompopulation-based
studies are sparse. We sought to investigate the prevalence and correlates of LADA.
RESEARCH DESIGN AND METHODS — A total of 8,109 participants, who were aged
15yearsandlivinginTianjin,China,wereassessedtoidentifyindividualswithtype2diabetes
(American Diabetes Association Criteria, 1997) and further to detect patients with LADA. LADA
was ascertained by 1) the presence of type 2 diabetes and age 35 years, 2) the lack of a
requirementforinsulinatleast6monthsafterthediagnosisoftype2diabetes,and3)serumGAD
antibody positivity. Data were analyzed using multinomial logistic regression with adjustment
for potential confounders.
RESULTS — Of all participants, 498 (6.1%) were patients with type 2 diabetes. Of them, 46
(9.2%) were found to have LADA. The prevalence of LADA was 0.6% (46 of 8,109), and tended
to increase with age up to 50–59 years in all participants. The odds ratios (95% CI) of LADA
related to hypertension, family history of diabetes, waist-to-hip ratio 0.85, and major stressful
events were 1.93 (1.02–3.65), 17.59 (9.08–34.06), 5.37 (2.31–12.49), and 4.09 (1.75–9.52),
respectively.
CONCLUSIONS — The prevalence of LADA is 9% in patients with type 2 diabetes. Hy-
pertension, family history of diabetes, central obesity, and major stressful events may be asso-
ciated with the occurrence of LADA.
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L
atent autoimmune diabetes in the
adult (LADA) is a slowly progressive
form of autoimmune diabetes and is
characterized by diabetes-associated au-
toantibody positivity (1). Patients with
LADA have an insidious onset of hyper-
glycemia and clinical presentation similar
to that of type 2 diabetes at onset (2,3).
Epidemiological studies suggest that
LADA may account for 2–12% of all cases
of diabetes (4).
The prevalence of LADA in western
countries varies from 2.8 to 10% in pa-
tients with type 2 diabetes (5–8). The Di-
abetes Outcomes Progression Trial
recently reported that GAD antibody
(GADA)positivityis4.2%inNorthAmer-
ica and 3.7% in Europe among individu-
alswithtype2diabetes(9).InChina,two
clinical studies have shown that the esti-
mated prevalence of LADA in patients
with type 2 diabetes is 7% (10,11). The
etiology of LADA is unclear, and it is not
known whether LADA is due to the same
underlying disease process as childhood
type 1 diabetes. A recent study has sug-
gested that the patients with LADA share
geneticfeatureswithbothtype1andtype
2 diabetic patients (12). In addition, sev-
eral studies have reported that metabolic
disorders, such as hypertension and obe-
sity, and a family history of diabetes are
associated with the risk of LADA
(10,13,14).
Accumulating clinical evidence has
shown signiﬁcant overlap between type 1
and type 2 diabetes. The disease process
in patients with classic type 1 diabetes is
believed to be autoimmune in nature,
whereasthediseaseprocessinclassictype
2 diabetes is not. The treatment for pa-
tientswithLADAmayneedtobedifferent
from that used for patients with type 2
diabetes(15).BecauseLADAisfrequently
misdiagnosed as type 2 diabetes, identiﬁ-
cation of LADA is of clinical importance.
In this population-based cross-sectional
study, we sought to investigate the prev-
alence of LADA and further to explore
whether familial, vascular, and psychoso-
cial factors are associated with the occur-
rence of LADA.
RESEARCH DESIGN AND
METHODS— The study population
was derived from the inhabitants of Tian-
jin, which is the third largest city and lo-
catedintheeastcoastalareainChina.The
city is composed of six urban districts, six
suburbs, and three newly developed ar-
eas. Each area contains 8–10 residential
communities, and each community con-
sisted of 8–10 blocks. The population of
the city is 11 million. In June 2005, a
multiphase stratiﬁed cluster sampling
method was implemented, and a random
sampleofthecitywasdrawnforthestudy
population. The strategy of sampling in
this study was designed on the basis of
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the sampling scheme for the Chinese Na-
tional Dietary and Nutrition Study in
Tianjin. In brief, a three-step randomized
sampling procedure was performed as
follows: ﬁrst, two urban districts and one
suburb were drawn as the ﬁrst-stage sam-
ple; second, three communities were se-
lected as the second-level unit; and,
ﬁnally, three neighborhoods were chosen
asthird-levelunit.Thereafter,atotalof18
urban and nine suburb blocks were in-
cluded in the study. All inhabitants (N 
8,540) who had lived in the selected
blocks for 5 years, who were aged 15
years, and who were type 1 diabetes free
were initially invited to participate in the
study. In July 2005, a two-phase survey
consisting of a screening phase and fur-
ther blood testing phase was imple-
mented. The screening phase included a
health interview, physical examination,
and fasting peripheral blood glucose test
for8,109(95.0%)participants.Inthesec-
ond phase, all subjects who had positive
screening results (fasting peripheral
blood glucose 5.4 mmol/l) were invited
to provide fasting and prandial blood
samples. Informed consent was received
from all participants. The ethics commit-
tee at the Tianjin Medical University ap-
proved the study.
Data collection
Data on age, sex, education, lifestyle,
health status, and family history of
chronicdiseaseandmajorstressfulevents
were collected from participants at the
screening phase through the interview
following a structured questionnaire. Ed-
ucation was categorized by the maximum
years of formal schooling and was dichot-
omized(9vs.9years).Familyhistory
ofdiabeteswasdeﬁnedashavingdiabetes
in any of the following family members:
parents, grandparents (either paternal
and maternal), and siblings. Height and
weight were measured without shoes and
heavy clothes. BMI was calculated as
weightinkilogramsdividedbythesquare
of height in meters. Waist circumference
wasmeasuredbetweenthelowerribmar-
gin and the anterior superior iliac spine,
and the hip circumference was measured
over the maximum of the buttocks.
Waist-to-hip ratio was calculated as waist
circumference (centimeters) divided by
hip circumference (centimeters) and di-
chotomized (0.85 vs. 0.85) based on
itsdistribution.Alcoholdrinkingwasalso
dichotomized (drinking at least once per
week vs. former drinker or never drink-
ing). Smoking status was categorized as
never, low (1–20 cigarettes/day), and
high (20 cigarettes/day). Experience of
major stressful events was deﬁned as job
or close relatives lost, frequent spousal
conﬂict, or accidents in the past 10 years.
Physicalactivityparticipationwasdichot-
omized as “regular” (two times or more
per week for at least 1 year) and
“nonregular.”
Diagnosis of type 2 diabetes and
LADA
Fasting peripheral blood glucose was
measured with a OneTouch ULTRA2
meter (Life Scan) at the screening phase
for all participants, and fasting and 2-h
postprandial venous blood samples were
takenforsubjectswhohadfastingperiph-
eral blood glucose 5.4 mmol/l at the
secondphase.Fastingplasmaglucoseand
2-h postprandial plasma glucose were
measured using a glucose oxidase proce-
dure. Type 2 diabetes was ascertained as
fasting plasma glucose 7.0 mmol/l or
postprandial 2-h plasma glucose 11.1
mmol/l according to the American Diabe-
tes Association diagnostic criteria (1997).
LADA was identiﬁed based on Immunol-
ogyofDiabetesSocietycriteria(16)asfol-
lows: 1) the presence of type 2 diabetes
and age 35 years; 2) a lack of require-
mentforinsulinatleast6monthsafterthe
diagnosisoftype2diabetes;and3)serum
GADA positivity as tested by radioligand
assay (17).
Statistical analyses
The characteristics of participants in dif-
ferent groups were compared using 
2
testsforcategoricalvariablesandone-way
ANOVA for continuous variables. The
prevalence rates were calculated as the
numberofsubjectswithLADAdividedby
number of subjects and standardized by
the structure of total population in the
city in 2005. Multinomial logistic regres-
sion analyses were used to estimate the
odds ratios (ORs) and 95% CI of LADA
and type 2 diabetes in relation to age, sex,
education,hypertension,familyhistoryof
diabetes, smoking, alcohol drinking,
physical activity, BMI, waist-to-hip ratio,
and major stressful events. LADA and
type 2 diabetes were used as separate out-
comes, and diabetes-free subjects were
used as the referent group in the multino-
mial logistic regression models. The anal-
yses were performed in participants aged
35 years (n  6,137) because of the ab-
sence of LADA in subjects aged 15–34
years. All statistical analyses were per-
formed using SPSS 17.0 (SPSS, Chicago,
IL).
RESULTS— The 8,109 participants
consisted of 3,878 (47.8%) men and
4,231 (52.2%) women (
2  15.37, P 
0.001). Age and sex distributions in our
study population were similar to the dis-
tributions in the source population in
Tianjin based on data from the Annual
Statistic Report, Tianjin, 2005. Among all
subjects, 498 (6.1%) had type 2 diabetes,
which included 268 (53.8%) with previ-
ously diagnosed diabetes and 230
(46.2%) with newly detected diabetes. Of
the 498 patients with type 2 diabetes, 46
(9.2%) were found to have LADA. Pa-
tients with LADA were more likely to be
older and obese, to have hypertension,
and to have a family history of diabetes
and stressful events but showed less alco-
hol drinking, compared with diabetes-
free subjects. The three groups did not
differ signiﬁcantly in terms of education
and smoking (Table 1).
Table 2 shows that the prevalence of
LADA was 9.2% (8.0% in women and
11.1% in men, P  0.253) in individuals
with type 2 diabetes. Among all partici-
pants, the prevalence of LADA was 0.6%
forbothmenandwomenandwas0.7%in
participants aged 35 years. The stan-
dardized prevalence of LADA was 0.69%
(0.68% in men and 0.70% in women),
which was based on the source popula-
tion aged 35 in Tianjin in 2005. With
age, the prevalence of LADA slowly in-
creased up to 50–59 years and seemed to
decline thereafter. However, the preva-
lence of type 2 diabetes was dramatically
elevated with age and tended to continu-
ously increase after age 60 years (Fig. 1).
In multinomial logistic regression,
hypertension, family history of diabetes,
high waist-to-hip ratio, and major stress-
ful events were signiﬁcantly associated
with both LADA and type 2 diabetes,
compared with diabetes-free subjects.
Age, female sex, and high BMI (25 kg/
m
2) were positively and alcohol drinking
was negatively related to type 2 diabetes.
Although these factors seemed to be asso-
ciated with LADA, the association did not
reach statistical signiﬁcance because of
the small number of patients with LADA
(Table 3). Regular physical activity (OR
0.95 [95% CI 0.49–1.84] for LADA and
0.91 [0.64–1.29] for type 2 diabetes) and
education (9 years) (0.99 [0.53–1.83]
forLADAand0.82[0.67–1.01]fortype2
diabetes)werenotsigniﬁcantlyassociated
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Compared with subjects who never
smoked, subjects who smoked low and
high numbers of cigarettes had ORs of
1.02 (95% CI 0.56–1.88) and 1.89
(0.44–8.02) for LADA and 0.89 (0.72–
1.10) and 1.50 (0.88–2.56) for type 2 di-
abetes, respectively. These results suggest
that LADA and type 2 diabetes might
share risk factors.
AstandardizedworkupfortheGADA
assay was performed in 50 patients with
newly diagnosed type 1 diabetes and 100
control subjects (mean age 32, range
4–80 years). The results showed that the
median area under the receiver operator
characteristic curve was 0.95 (86% sensi-
tivity and 95% speciﬁcity).
CONCLUSIONS — Inthislargepop-
ulation-based cross-sectional study, we
found that 1) the prevalence of LADA is
9.2% among individuals with type 2 dia-
betes and 0.6% in all participants, 2) the
prevalence slowly increased with age up
to 60 years and was high in individuals
aged 50–59 years, and 3) hypertension,
family history of diabetes, high waist-to-
hip ratio, and experience of stressful
events are related to the occurrence of
LADA. Given the high prevalence of dia-
betes worldwide, our ﬁndings are of clin-
ical importance.
The prevalence of LADA varies ac-
cording to the populations involved, cri-
teriaused,andantibodiesanalyzed.Ithas
become clear that LADA accounts for
10% of initial diagnoses of type 2 dia-
betes (18). Epidemiological studies have
shown conﬂicting results on the differ-
ences in LADA prevalence in terms of age
and sex among people with type 2 diabe-
tes. One study showed a male predomi-
nance of LADA, whereas other studies
found a higher prevalence among women
(6,19). Another study reported that the
prevalence of GADA positivity is 0.9% in
a Spanish population aged 18–65 years
(20). In this population-based cross-
sectionalstudy,wefoundthat1)theprev-
alence of LADA is 9.2% among
individualswithtype2diabetesand0.6%
in all participants and 2) the prevalence is
not sex speciﬁc but is high in individuals
aged 50–59 years.
Autoimmunity is the major cause of
type 1 diabetes and is assumed to be the
cause of LADA, which shares the bio-
chemical marker of -cell–directed auto-
immunity with classic type 1 diabetes
(21). Thus, LADA is considered a “mild”
formoftype1diabetes,whichshowsslow
progression to insulin dependence. The
fact that HLA-DR4-DQ8 antigens are
more widespread among patients with
classic type 1 diabetes than among those
with LADA may offer an explanation as to
why patients with LADA do not develop
insulin dependence as quickly as patients
with classic type 1 diabetes (22).
The risk factors for LADA are less well
understoodthanthosefortype1andtype2
diabetes.Ageandoverweightareimportant
risk factors for type 2 diabetes. Whether
these factors also increase the risk of LADA
is unclear. Previous studies based on cross-
sectionaldatahaveshownthatpatientswith
LADA were younger and less obese than
type 2 diabetic subjects (5) or found these
variables to be similar in those with type 2
diabetes. A population-based prospective
study has shown the risk effect of age, over-
weight, and physical inactivity on LADA
(14). A cross-sectional study indicated that
family history of diabetes is a strong risk
factorforLADAbecauseofacombinationof
shared genetic and environmental factors
(13). In addition, a recent clinical study re-
ported patients with LADA having more
metabolic disorders such as hypertension
and overweight (10). In the present study,
we found that hypertension, family history
of diabetes, high waist-to-hip ratio, and ex-
perienceofmajorstressfuleventsarerelated
to both LADA and type 2 diabetes, suggest-
ing that LADA and type 2 diabetes might
share risk factors. However, the statistical
power was limited for the analyses of other
Table 1—Characteristics of the study participants by type 2 diabetes and LADA
Characteristics Nondiabetes Type 2 diabetes LADA P value
n (%) 7,611 (93.8) 452 (5.6) 46 (0.6)
Age (years) 45.8  15.3 55.9  10.4 53.9  7.8 0.001
Female sex 3,932 (51.7) 275 (60.8) 24 (52.2) 0.001
Education (9 years) 2,504 (33.0) 130 (28.8) 15 (32.6) 0.182
Smoking 2,770 (36.4) 168 (37.3) 21 (45.7) 0.406
Alcohol drinking* 2,076 (28.0) 86 (19.5) 11 (23.9) 0.001
Hypertension* 1,265 (17.1) 191 (42.5) 16 (34.8) 0.001
Family history of diabetes* 181 (2.7) 137 (30.4) 15 (32.6) 0.001
Major stressful events* 237 (3.1) 84 (18.8) 7 (15.2) 0.001
BMI* 24.0  3.4 26.2  3.5 25.7  3.4 0.001
Underweight (20 kg/m
2) 788 (10.4) 11 ( 2.5) 1 ( 2.2)
Normal (20–24.99 kg/m
2) 4,094 (53.8) 164 (36.7) 17 (37.0)
Overweight (25–29.99 kg/m
2) 2,361 (31.0) 216 (48.3) 23 (50.0)
Obese (30 kg/m
2) 368 ( 4.8) 56 (12.5) 5 (10.9) 0.001
Waist-to-hip ratio (0.85)* 3,825 (50.3) 347 (78.2) 38 (82.6) 0.001
Data are n (%) or means  SD. n  8,109. *Numbers of subjects with missing values were 195 for alcohol
drinking, 162 for hypertension, 803 for family history of diabetes, 43 for major stressful events, 5 for BMI,
and 11 for waist-to-hip ratio.
Table 2—Prevalence of LADA in patients with type 2 diabetes and all participants
Age
LADA in patients with type 2 diabetes LADA in all participants
Male Female Total Male Female Total
n 498 8,109
40 years 1/12 (8.3) 1/20 (5.0) 2/32 (6.3) 1/1,221 (0.1) 1/1,372 (0.1) 2/2,593 (0.1)
40–49 years 2/33 (6.1) 6/57 (10.5) 8/90 (8.9) 2/931 (0.2) 6/975 (0.6) 8/1,906 (0.4)
50–59 years 12/77 (15.6) 14/110 (12.7) 26/187 (13.9) 12/948 (1.3) 14/1,021 (1.4) 26/1,969 (1.3)
60 years 7/77 (9.1) 3/112 (2.7) 10/189 (5.3) 7/778 (0.9) 3/863 (0.3) 10/1,641 (0.6)
Total 22/199 (11.1) 24/299 (8.0) 46/498(9.2) 22/3,878 (0.6) 24/4,231 (0.6) 46/8,109 (0.6)
Data are n (%) unless otherwise indicated.
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berofpatientswithLADAinourstudy.Fur-
ther population-based longitudinal studies
are warranted to clarify the temporality for
the relationships between these factors and
LADA risk.
The main strengths of our study are
the large population-based sample, the
randomized sampling procedure, the di-
agnosis of diabetes based on both fasting
and prandial plasma glucose level, and
the identiﬁcation of individuals with
LADA by GADA positivity. However,
some limitations need to be pointed out.
First, we used fasting peripheral blood
glucoseratherthanfastingplasmaglucose
as the screening test; thus, patients with
diabetes might have been misclassiﬁed in
the nondiabetes group, which would at-
tenuate our results. In addition, individ-
uals with a severe or long-standing
chronicdisease,e.g.,diabetes,mighthave
refused to participate in this study be-
cause of their unhealthy condition. On
the other hand, it is possible that individ-
uals with mild type 2 diabetes might be
more interested in participation than
those without this condition. However,
theparticipationratewashigh(95%),and
the prevalence of type 2 diabetes in this
study is comparable to that in previous
reports. Thus, the participation bias
might not be substantial. Second, the def-
inition used for LADA as age 35 years
might be arbitrary. Yet, in our study, all
patients with type 2 diabetes who were
aged 35 years were GADA negative.
Third, information on the presence of
current and past disease and family his-
tory of diabetes was mainly based on self-
report. Subjects with diabetes are
probably more likely to be aware of rela-
tives with diabetes; therefore, recall bias
may not be ruled out. However, the prev-
alence of smoking and hypertension in
our study was similar to the prevalence
reported by other studies. In addition, in-
formation on several diabetes-related dis-
eases such as cerebrovascular disease and
coronary heart disease was not available.
Finally, the temporality of the given asso-
ciations is unclear because of the cross-
sectional design of this study.
Insummary,ourresultsshowthatthe
prevalence of LADA is 9% among indi-
viduals with type 2 diabetes and high in
individuals aged 50–59 years. Hyperten-
sion, family history of diabetes, high
waist-to-hip ratio, and experiences of
stressfuleventsareassociatedwiththeoc-
currence of LADA, suggesting the in-
volvement of both genetic and
environmentalfactorsinLADA.Giventhe
high prevalence of type 2 diabetes world-
wide, our ﬁndings highlight the need to
identify patients with LADA for proper
treatment. Further population-based lon-
gitudinalstudiesarerequiredtoverifythe
risk factors for the development of LADA.
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